German Adrenocortical Carcinoma Registry
ConditionAdrenocortical Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Wuerzburg
About this trial
Basic objective of the German Adrenocortical Carcinoma Registry is to improve the care of patients with adrenocortical cancer. The registration of as many patients as possible helps to collect data for the prognosis and prospects of success regarding different treatment plans. This data will be taken into consideration for planning prospective studies. With this registry, the recruitment of patients for prospective studies will be significantly facilitated. In this way - and in cooperation with networks in other countries (e.g. in Italy and France) - a structure allowing systematic improvement of therapy will be developed.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Histologically confirmed diagnosis of adrenocortical carcinoma
Disqualifiers
None
Trial population
Adrenocortical carcinoma patients in Germany (or treated in Germany)
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
1,000 Participants
are grouped into 1 trial groupGroup A: Adrenocortical carcinoma
Trial outcomes
Primary outcomes
1
Overall Survival
overall survival is defined as the length of time from diagnosis or the start of treatment until death from any cause.
Time frame
From date of diagnosis until the date of death from any cause (or last follow-up), whichever came first, assessed up to 100 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Wuerzburg
Lead sponsor
Deutsche Krebshilfe e.V., Bonn (Germany)
Collaborator
Source ClinicalTrials.gov